Registration - Consultant Lobbyist

Innovative Medicines Canada / Greg D'Avignon, Consultant Lobbyist

Registration Information

Client name: Innovative Medicines Canada
Lobbyist name: Greg D'Avignon, Consultant Lobbyist
Initial registration start date: 2025-09-11
Registration status: Inactive
Registration number: 1251-6178

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 3

Lobbying Activity Reports - last 6 months: 1

Version 1 of 1 (2025-09-11 to 2026-08-19)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will the consultant lobbyist be arranging meetings between a public office holder and the client for the purpose of attempting to influence any of the matters listed:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Engaging with the Government of British Columbia to advocate for expanding research, investment, and job creation opportunities in British Columbia’s life sciences and research and development ecosystem.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Employment and Training, Finances and Budgets, Health, Hospitals, Science and Technology
Engaging with the Government of British Columbia to advocate for innovative procurement of medicines within the health system to improve patient outcomes, including approaches that leverage real-world data to assess effectiveness.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Government Procurement, Health, Hospitals
Engaging with the Government of British Columbia to ensure patient access to innovative medicines, support continued research investment, and encourage federal advocacy on the proposed Patented Medicine Prices Review Board regulatory changes.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade
Engaging with the Government of British Columbia to ensure recognition of the value of Innovative Medicines in improving patient outcomes, enhancing system efficiency, and fostering economic growth through sustained investment in the drug plan.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Employment and Training, Finances and Budgets, Health, Hospitals, Science and Technology

BC Ministries/Provincial Entities

Health
Indigenous Relations and Reconciliation
Jobs and Economic Growth
Member(s) of the BC Legislative Assembly
Office of the Premier
Parliamentary Secretary for Rural Health
Provincial Health Services Authority

Contingency Information

Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the outcome of this lobbying activity.
Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the success in arranging a meeting with public office holders on behalf of the client.

Client Details

Client Contact Information

Innovative Medicines Canada

Address:
55 Metcalfe Street, Suite 1220
Ottawa, ON K1P 6L5
Canada

Website: https://innovativemedicines.ca/

Description of Business Activities

Innovative Medicines Canada partners to champion policies that drive the discovery, investment in development and delivery of transformative medicines and vaccines to all Canadians while supporting patients to live longer and healthier lives.

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was received within the preceding 12 months based on the submission date requirements for this registration.

Other Entities (working together for the purposes of lobbying) Information

Innovative Medicines Canada is not working together with any other entity for the purpose of lobbying.

Affiliates with a Direct Interest in the Outcome

Innovative Medicines Canada does not have any affiliates that could have a direct interest in the outcome of the lobbying activities

Other Persons or Organizations with Direct Interests

The activities of Innovative Medicines Canada are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyist Details

Greg D'Avignon | Has not held any “former public office holder” positions in BC, as defined in the Lobbyists Transparency Act

Business address:
10103 97A Avenue NW
Edmonton, AB T5K 2T3
Canada

Relevant Codes of Conduct

The consultant lobbyist does not have in place an undertaking to comply with any relevant codes of conduct.

Political, Sponsorship and Recall Contributions

Consultant has lobbied, or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, on or after 2024-09-21:

Yes

Has made a political contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	Yes
	Client:	No
Has made a sponsorship contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No
Has made a recall contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No

Details of the political, sponsorship or recall contributions can be found at the Financial Reports and Political Contributions System (FRPC) website.

Gifts or Benefits Provided to Public Officer Holders

No gifts or benefits were provided to public office holders

Individuals Hired or Subcontracted to Lobbying on behalf of the Client

Brent Korte

Consultant Lobbyist Firm and Address

Firm: CSG Canadian Strategy Group LP

Address:
10103 97A Avenue NW
Edmonton, AB T5K 2T3
Canada

Innovative Medicines Canada

Name change history

Name change history
Name	From	To
Innovative Medicines Canada	2025-09-11	2026-08-19

Innovative Medicines Canada

Senior Officer History
Senior Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Greg D'Avignon, CSG Canadian Strategy Group LP (Consultant Lobbyist)

Learn more...

Designated Filers are required to submit a Lobbying Activity Report for each lobbying activity with a senior public officer holder. The name of the most senior paid officer (i.e. the designated filer) will appear on all in-house Lobbying Activity Reports, whether or not he/she participated in the activity.

Note: Lobbying Activity Reports are due on the 15^th day of each month for lobbying activities that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-3 of 3

Innovative Medicines Canada
Consultant Lobbyist: Greg D'Avignon

Senior Public Office Holders who were lobbied in this activity:
- Ravi Kahlon, Minister of Jobs and Economic Growth | Member(s) of the BC Legislative Assembly
- Trevor Halford, MLA for Surrey-White Rock | Member(s) of the BC Legislative Assembly
Lobbying Activity date: 2026-03-30
Posted date: 2026-04-07
Lobbying Activity number: 6178-50285 View Lobbying Activity Report
Innovative Medicines Canada
Consultant Lobbyist: Greg D'Avignon

Senior Public Office Holders who were lobbied in this activity:
- Maija Duffy, Executive Director, Life Sciences | Jobs and Economic Growth
- Cecile Lacombe, Executive Project Director | Jobs and Economic Growth
Lobbying Activity date: 2026-01-09
Posted date: 2026-01-13
Lobbying Activity number: 6178-48473 View Lobbying Activity Report
Innovative Medicines Canada
Consultant Lobbyist: Greg D'Avignon

Senior Public Office Holders who were lobbied in this activity:
- Ravi Kahlon, Minister of Jobs and Economic Growth | Member(s) of the BC Legislative Assembly
Lobbying Activity date: 2025-09-11
Posted date: 2025-09-19
Lobbying Activity number: 6178-45502 View Lobbying Activity Report

Greg D'Avignon, CSG Canadian Strategy Group LP (Consultant Lobbyist)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-3 of 3

Innovative Medicines Canada
Consultant Lobbyist: Greg D'Avignon

Senior Public Office Holders who were lobbied in this activity:
- Ravi Kahlon, Minister of Jobs and Economic Growth | Member(s) of the BC Legislative Assembly
- Trevor Halford, MLA for Surrey-White Rock | Member(s) of the BC Legislative Assembly
Lobbying Activity date: 2026-03-30
Posted date: 2026-04-07
Lobbying Activity number: 6178-50285 View Lobbying Activity Report

Date Modified:: 2026-08-18

Menus

www.lobbyistsregistrar.bc.ca

Registration - Consultant Lobbyist

Innovative Medicines Canada / Greg D'Avignon, Consultant Lobbyist

Registration Information

Associated Lobbying Activity Reports

Version 1 of 1 (2025-09-11 to 2026-08-19)

Version 1 of 1 (2025-09-11 to 2026-08-19)

Details Regarding the Identified Subject Matter

BC Ministries/Provincial Entities

Contingency Information

Client Contact Information

Description of Business Activities

Contributors to the Lobbying Activity

Government Funding in the Last 12 Months

Other Entities (working together for the purposes of lobbying) Information

Affiliates with a Direct Interest in the Outcome

Other Persons or Organizations with Direct Interests

Relevant Codes of Conduct

Political, Sponsorship and Recall Contributions

Gifts or Benefits Provided to Public Officer Holders

Individuals Hired or Subcontracted to Lobbying on behalf of the Client

Consultant Lobbyist Firm and Address